Radiation and Cancer Biology

Panel 06 - The Translational Potential of Liquid Biopsies for Predicting Radiation Response

Utilizing liquid biopsies in radiation oncology.

Monday, October 22
10:45 AM - 11:05 AM
Location: Room 304

Scott Bratman, MD, PhD

Princess Margaret Hospital

Disclosure:
Employment
University Health Network: Staff Radiation Oncologist - Clinician Scientist: Employee

Ownership
Inventor on patent: Patent/License Fees/Copyright

Biography:
Dr. Scott Bratman is an Assistant Professor of Radiation Oncology and Medical Biophysics at the University of Toronto and a Scientist at the Princess Margaret Cancer Research Institute. He also serves as Clinician-Scientist in the Radiation Medicine Program at The Princess Margaret Cancer Centre. Dr. Bratman was trained at Princeton University, Columbia University Medical Center, and Stanford Cancer Institute. At Stanford he performed postdoctoral research studies with Drs. Max Diehn and Ash Alizadeh and published a landmark study on liquid biopsies for lung cancer patients. Since moving to Toronto in 2014, his research and clinical focus has been on head and neck cancer. The Bratman Lab is currently developing and validating new liquid biopsy tools for detecting the presence of cancer. The team is also interested in genomic tools and other biomarkers for personalized use of radiotherapy for head and neck cancer patients.

Presentation(s):

Send Email for Scott Bratman


Assets

Utilizing liquid biopsies in radiation oncology.



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Utilizing liquid biopsies in radiation oncology.